Description
Description
Peripheral neuropathy is a syndrome, which is a single or any combination form of sensory loss, muscle weakness and atrophy, decreased tendon reflex and vasomotion symptoms. The factors which lead to peripheral neuropathy are that the damage of single neural limitation is a common cause of trauma, while multiple single neuropathy occurs secondary to collagen vascular disease; Multiple neuropathy may be caused by toxins, toxic substances, nutrition deficiency, metabolic disease and malignant tumors.
Methylcobalamin, derivative of Vitamin B12, is active Vitamin B12 and the therapeutic drug of peripheral neuropathy. It can promote intraneural nucleic acid, protein and metabolism, facilitate the synthesis of DNA,RNA as well as the synthesis of lecithin lipid, which is the main component of myelin sheath, and accelerate to restore the damaged nerve tissue to improve the transformation of nerve tissue and the disturbance of metabolism. In addition, it also works on restraining unusual exciting conduction of nerve tissue.
Methylcobalamin,. whose trade name is mecobalamin, was developed by Eisai Co., Ltd. and put in the market in Japan in the middle of 1980s.In 1996, mecobalamin entered the Chinese market.
Methylcobalamin developed rapidly after entering China. Its annual sales value increased from less than 200 million CNY in 2005 to 441 million CNY in 2014, with CAGR of 12.32%. It had broad market demand in China. Eisai (Suzhou) Pharmaceutical Co., Ltd, Eisai Co., Ltd. (Japan), Jiangsu Sihuan Bioengineering Co., Ltd, Nanjing Hailing Pharmaceutical Co., Ltd. and NCPC occupy large market share, among which Eisai (Suzhou) Pharmaceutical Co., Ltd occupies most, whose annual market share of sales value was over 40% in 2014.
It is predicted that in next few years, the incidence of peripheral neuropathy in China will gradually rise, making the market scale of methylcobalamin continue to increase.
Through this report, readers can get the followings and more information:
-Market scale of Methylcobalamin in China
-Market Competitive pattern of Methylcobalamin in China
-Sales price of Methylcobalamin made by different enterprises in China
-Market outlook of Methylcobalamin in China
The author recommends the following people to purchase this report:
– Production enterprises of methylcobalamin drugs
-Investors/research institutions focusing on Chinese pharmaceutical market
–If interested in Chinese pharmaceutical market, you can contact CRI for customized survey service.
Table of Contents
1 Related Concepts of Methylcobalamin
1.1 Indications
1.2 Sales Status in Global Market
2 Market Profile of Methylcobalamin in China
2.1 Patent and Approval Information of Methylcobalamin in China
2.2 Major Manufacturing Enterprises
2.3 Market Scale
3 Survey on Methylcobalamin Sales in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 Survey on Market Share of Major Methylcobalamin Production Enterprises in China, 2010-2014
4.1 Market Share of Producing Businesses by Sales Value
4.2 Market Share of Producing Businesses by Sales Volume
5 Survey on Dosage Forms of Methylcobalamin in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 Reference Sales Price of Methylcobalamin in Chinese Hospitals in 2014
6.1 North China Pharmaceutical Group Corp. (NCPC)
6.2 Eisai (Suzhou) Pharmaceutical Co., Ltd.
6.3 Eisai Co., Ltd. (Japan)
6.4 Nanjing Hailing Pharmaceutical Co., Ltd.
6.5 Jiangsu Sihuan Bioengineering Co., Ltd.
7 Major Production Enterprises of Methylcobalamin in Chinese Market, 2010-2014
7.1 North China Pharmaceutical Group Corp. (NCPC)
7.2 Eisai (Suzhou) Pharmaceutical Co., Ltd.
7.3 Eisai Co., Ltd. (Japan)
7.4 Nanjing Hailing Pharmaceutical Co., Ltd.
7.5 Jiangsu Sihuan Bioengineering Co., Ltd.
8 Market Outlook of Methylcobalamin in China, 2015-2019
8.1 Prediction of Market Size
8.2 Prediction of Competitive Pattern
Selected Charts
Chart Patent Status of Methylcobalamin in China
Chart Approval Information of Methylcobalamin in China
Chart Sales Status of Methylcobalamin in China
Chart Sales Value of Methylcobalamin in China, 2010-2014
Chart Sales Value of Methylcobalamin in Some Regions of China, 2010-2014
Chart Sales Volume of Methylcobalamin in China, 2010-2014
Chart Sales Volume of Methylcobalamin in Some Regions of China, 2010-2014
Market Share of Corporations of TOP5 Methylcobalamin Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by Eisai (Suzhou) in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by Eisai (Japan) in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by Jiangsu Sihuan in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by Nanjing Hailing in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by NCPC in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Injection in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Tablet in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Capsule in China, 2010-2014
Chart Sales Price of Methylcobalamin Produced by NCPC in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Eisai (Suzhou) in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Eisai (Japan) in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Nanjing Hailing Pharmaceutical Co., Ltd. in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Jiangsu Sihuan Bioengineering Co., Ltd. in Some Chinese Cities in 2014
